Literature DB >> 19902226

Effects of ovarian failure on submucosal collagen and blood vessels of the anal canal in postmenopausal women.

Hosam Ghazy Elbanna1, Amr Medhat Abbas, Khaled Zalata, Mohamed Farid, Wageh Ghanum, Mohamed Youssef, Waleed Mohamed Thabet, Saleh El Awady, Mohamed H Abd El-Sattar.   

Abstract

BACKGROUND: Estrogen and progesterone receptors are expressed in the anal canal. Fecal control deteriorates after menopause. This phenomenon is related to decreased circulating levels of estrogen and progesterone due to ovarian failure at menopause. AIM OF WORK: To study the effects of estrogen and progesterone on inflammatory cells, submucosal collagen fibers, and vascular plexus of the anal canal of postmenopausal women. SUBJECTS AND METHODS: Experiments were performed on samples of anorectal tissue obtained from 40 women, 19 menstruating (group I), and 21 postmenopausal women (group II). Investigations included immunohistochemistry of estrogen and progesterone receptors and CD34.
RESULTS: In negative estrogen receptors (ER) and progesterone receptors (PR), inflammatory cells, submucosal blood vessels, collagen type I were nonsignificantly changed in postmenopausal women relative to menstruating women (P > 0.05) whereas, in positive ER and PR, inflammatory cells and collagen I were significantly increased and submucosal blood vessels were significantly decreased in postmenopausal women relative to menstruating women (P < 0.05).
CONCLUSION: Estrogen and progesterone, in menstruating women, produce beneficial effects by decreasing incidence of inflammation and increasing anal canal submucosal blood vessels number and collagen types I, thus both hormones have a positive effect on anal compliance and pressure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19902226     DOI: 10.1007/s00384-009-0820-1

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  26 in total

1.  Bladder neck circulation by Doppler ultrasonography in postmenopausal women with urinary stress incontinence.

Authors:  E Tsai; C Yang; H Chen; C Wu; J Lee
Journal:  Obstet Gynecol       Date:  2001-07       Impact factor: 7.661

2.  Epidemiology and changing demographics of overactive bladder: a focus on the postmenopausal woman.

Authors:  Jeanette S Brown
Journal:  Geriatrics       Date:  2002-05

3.  Shaping future directions for incontinence research in aging adults: executive summary.

Authors:  Jean F Wyman; Donna Z Bliss; Molly C Dougherty; Mikel Gray; Merrie Kaas; Diane K Newman; Mary H Palmer; Thelma J Wells
Journal:  Nurs Res       Date:  2004 Nov-Dec       Impact factor: 2.381

4.  Changes of collagen type III in female patients with genuine stress incontinence and pelvic floor prolapse.

Authors:  A Liapis; P Bakas; A Pafiti; M Frangos-Plemenos; N Arnoyannaki; G Creatsas
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2001-07       Impact factor: 2.435

5.  Influence of bilateral oophorectomy and estrogen substitution on the striated anal sphincter in adult female rats.

Authors:  U B Knudsen; S Laurberg; C C Danielsen
Journal:  Scand J Gastroenterol       Date:  1991-07       Impact factor: 2.423

6.  Anorectal manometry before, during and after estrogen replacement therapy.

Authors:  R P Schellart; W R Schouten; F J Huikeshoven
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

Review 7.  Imaging of fistula in ano.

Authors:  Steve Halligan; Jaap Stoker
Journal:  Radiology       Date:  2006-04       Impact factor: 11.105

8.  Localization of steroid hormone receptors in the pelvic muscles.

Authors:  P Smith; G Heimer; A Norgren; U Ulmsten
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1993-06       Impact factor: 2.435

Review 9.  Sex hormones, the menopause and urinary problems.

Authors:  L D Cardozo; C J Kelleher
Journal:  Gynecol Endocrinol       Date:  1995-03       Impact factor: 2.260

10.  Estrogen receptors in the external anal sphincter.

Authors:  K Haadem; L Ling; M Fernö; H Graffner
Journal:  Am J Obstet Gynecol       Date:  1991-02       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.